224 related articles for article (PubMed ID: 17692741)
21. Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention.
Duffy BK; Gurm HS; Rajagopal V; Gupta R; Ellis SG; Bhatt DL
Am J Cardiol; 2006 Apr; 97(7):993-6. PubMed ID: 16563903
[TBL] [Abstract][Full Text] [Related]
22. Hypertension is an independent risk factor for contrast nephropathy after percutaneous coronary intervention.
Conen D; Buerkle G; Perruchoud AP; Buettner HJ; Mueller C
Int J Cardiol; 2006 Jun; 110(2):237-41. PubMed ID: 16298441
[TBL] [Abstract][Full Text] [Related]
23. Association Between Contrast Volume-to-Creatinine Clearance Ratio and the Risk of Perioperative Myocardial Infarction After Elective Percutaneous Coronary Intervention.
Li Y; Zhao L; Xu T; Lv Q; He J; Wang Y; Fu G; Zhang W
Int Heart J; 2022 Sep; 63(5):798-805. PubMed ID: 36104241
[TBL] [Abstract][Full Text] [Related]
24. Clinical characteristics and early mortality of patients undergoing coronary artery bypass grafting compared to percutaneous coronary intervention: insights from the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and the Melbourne Interventional Group (MIG) Registries.
Yan BP; Clark DJ; Buxton B; Ajani AE; Smith JA; Duffy SJ; Shardey GC; Skillington PD; Farouque O; Yii M; Yap CH; Andrianopoulos N; Brennan A; Dinh D; Reid CM; ;
Heart Lung Circ; 2009 Jun; 18(3):184-90. PubMed ID: 19268632
[TBL] [Abstract][Full Text] [Related]
25. Effects of body habitus on contrast-induced acute kidney injury after percutaneous coronary intervention.
Kuno T; Numasawa Y; Sawano M; Katsuki T; Kodaira M; Ueda I; Suzuki M; Noma S; Negishi K; Ishikawa S; Miyata H; Fukuda K; Kohsaka S
PLoS One; 2018; 13(9):e0203352. PubMed ID: 30212493
[TBL] [Abstract][Full Text] [Related]
26. Troponin ratio and risk stratification in subjects with acute coronary syndrome undergoing percutaneous coronary intervention.
Brunetti ND; Quagliara D; Di Biase M
Eur J Intern Med; 2008 Oct; 19(6):435-42. PubMed ID: 18848177
[TBL] [Abstract][Full Text] [Related]
27. Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) study.
Patti G; Nusca A; Mangiacapra F; Gatto L; D'Ambrosio A; Di Sciascio G
J Am Coll Cardiol; 2008 Sep; 52(14):1128-33. PubMed ID: 18804738
[TBL] [Abstract][Full Text] [Related]
28. Incidence, predictors, and clinical impact of bleeding after transradial coronary stenting and maximal antiplatelet therapy.
Bertrand OF; Larose E; Rodés-Cabau J; Gleeton O; Taillon I; Roy L; Poirier P; Costerousse O; Larochellière RD
Am Heart J; 2009 Jan; 157(1):164-9. PubMed ID: 19081414
[TBL] [Abstract][Full Text] [Related]
29. Predicting major adverse cardiac events after percutaneous coronary intervention: the Texas Heart Institute risk score.
Madan P; Elayda MA; Lee VV; Wilson JM
Am Heart J; 2008 Jun; 155(6):1068-74. PubMed ID: 18513521
[TBL] [Abstract][Full Text] [Related]
30. The evaluation of creatinine clearance, estimated glomerular filtration rate and serum creatinine in predicting contrast-induced acute kidney injury among patients undergoing percutaneous coronary intervention.
Robert AM; Brown JR; Sidhu MS; Ramanath VS; Devries JT; Jayne JE; Hettleman BD; Friedman BJ; Niles NW; Kaplan AV; Malenka DJ; Robb JF; Thompson CA;
Cardiovasc Revasc Med; 2012; 13(1):3-10. PubMed ID: 22093591
[TBL] [Abstract][Full Text] [Related]
31. Combined impact of age and estimated glomerular filtration rate on in-hospital mortality after percutaneous coronary intervention for acute myocardial infarction (from the American College of Cardiology National Cardiovascular Data Registry).
Cardarelli F; Bellasi A; Ou FS; Shaw LJ; Veledar E; Roe MT; Morris DC; Peterson ED; Klein LW; Raggi P
Am J Cardiol; 2009 Mar; 103(6):766-71. PubMed ID: 19268729
[TBL] [Abstract][Full Text] [Related]
32. Predictors and clinical significance of angiographically detected distal embolization after primary percutaneous coronary interventions.
Izgi A; Kirma C; Tanalp AC; Dundar C; Oduncu V; Aung SM; Sonmez K; Mutlu B; Mansuroglu D
Coron Artery Dis; 2007 Sep; 18(6):443-9. PubMed ID: 17700215
[TBL] [Abstract][Full Text] [Related]
33. Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid.
Maslow AD; Chaudrey A; Bert A; Schwartz C; Singh A
J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):6-15. PubMed ID: 18249324
[TBL] [Abstract][Full Text] [Related]
34. Effect of mean platelet volume on postintervention coronary blood flow in patients with chronic stable angina pectoris.
Duygu H; Turkoglu C; Kirilmaz B; Turk U
J Invasive Cardiol; 2008 Mar; 20(3):120-4. PubMed ID: 18316827
[TBL] [Abstract][Full Text] [Related]
35. Disparities in use of same-day percutaneous coronary intervention for patients with ST-elevation myocardial infarction in Florida, 2001-2005.
Pathak EB; Strom JA
Am J Cardiol; 2008 Oct; 102(7):802-8. PubMed ID: 18805101
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of epicardial blood flow before and after percutaneous coronary intervention in patients with acute coronary syndromes.
Ndrepepa G; Mehilli J; Schulz S; Iijima R; Keta D; Byrne RA; Pache J; Seyfarth M; Schömig A; Kastrati A
J Am Coll Cardiol; 2008 Aug; 52(7):512-7. PubMed ID: 18687242
[TBL] [Abstract][Full Text] [Related]
37. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV;
Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033
[TBL] [Abstract][Full Text] [Related]
38. Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry.
Jeremias A; Kleiman NS; Nassif D; Hsieh WH; Pencina M; Maresh K; Parikh M; Cutlip DE; Waksman R; Goldberg S; Berger PB; Cohen DJ;
Circulation; 2008 Aug; 118(6):632-8. PubMed ID: 18645057
[TBL] [Abstract][Full Text] [Related]
39. The impact of advanced chronic kidney disease on in-hospital mortality following percutaneous coronary intervention for acute myocardial infarction.
Vasu S; Gruberg L; Brown DL
Catheter Cardiovasc Interv; 2007 Nov; 70(5):701-5. PubMed ID: 17932900
[TBL] [Abstract][Full Text] [Related]
40. Timing and duration of myocardial ischemia on Holter monitoring following percutaneous coronary intervention and their association with clinical outcomes (a PROTECT-TIMI 30 Substudy Analysis).
Gibson CM; Pride YB; Buros JL; Ciaglo LN; Morrow DA; Scirica BM; Stone PH;
Am J Cardiol; 2009 Jul; 104(1):36-40. PubMed ID: 19576318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
